This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

YongSung Kim
Professor at Ajou University
Speaker

Profile

Dr. Yong-Sung Kim has been a professor of Dept. of Molecular Science and Technology at Ajou University (Suwon, Korea) since 2004. Dr. Kim obtained his M.Sc. in Biotechnology in 1998 from KAIST (Daejon, Korea) and Ph.D. in Pharmaceutical Sciences in 2002 from the University of Colorado, Denver, USA. He did post-doc in Prof. K. Dane Wittrup lab at MIT. He also spent one year (2010-2011) during his Sabbatical at Genentech Inc. (SF, USA).


Dr. Kim’s research focuses on development of next generation antibody platform technology for potent anti-cancer therapeutics, including heterodimeric Fc-based bispecific antibody, solid tumor-penetrating antibody platform, and cytosol-penetrating antibody platform technology. Based on the cellular cytosol-penetrating antibody technology, Dr. Kim co-founded Orum Therapeutics Inc. in 2016. His website is http://antibody.ajou.ac.kr/.